Novartis Investigative Site

Poissy 78303

0 studies enrolling now · 2 studies all time

What they study most

Relapsing Forms of Multiple Sclerosis, Relapsing Multiple Sclerosis

Studies at this site

• Efficacy and Safety of Remibrutinib Compared to Teriflunomide in Participants With Relapsing Multiple Sclerosis (RMS) — Running, not enrolling
• Long-term Safety and Tolerability of 0.5 mg Fingolimod in Patients With Relapsing Forms of Multiple Sclerosis — Completed